Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ramalingam

Showing results (221-230 of 502) with videos related to

Pageof 51
Sort By:
Cancer Biology & Therapy|January 13, 2012
Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancerYikun Li, Songqing Fan, Junghui Koo, et al.
Cancer Biology & Therapy|July 9, 2011
Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagyCheng-Xiong Xu, Liqun Zhao, Ping Yue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guidelineNatasha B Leighl, Natasha Rekhtman, William A Biermann, et al.
Cancer|April 22, 2020
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16qBrian Pedro, Manali Rupji, Bhakti Dwivedi, et al.
The Oncologist|September 30, 2024
Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancerJaime Shaw, Xerxes Pundole, Akhila Balasubramanian, et al.
Journal of Health Care for the Poor and Underserved|August 18, 2025
A Report on Georgia Cancer Disparities and an Economic Evaluation of a Statewide Cancer Clinicians and Scholars' ProgramJon A Hoin, Kylie Brown, Joseph Lipscomb, et al.
Frontiers in Oncology|February 11, 2026
TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naïve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterationsThomas Newsom-Davis, Barbara Melosky, Rebecca S Heist, et al.
Clinical and Diagnostic Laboratory Immunology|November 4, 2000
Molecular confirmation of human immunodeficiency virus (HIV) type 2 in HIV-seropositive subjects in south IndiaR Kannangai, S Ramalingam, K J Prakash, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 22, 2001
A peptide enzyme linked immunosorbent assay (ELISA) for the detection of human immunodeficiency virus type-2 (HIV-2) antibodies: an evaluation on polymerase chain reaction (PCR) confirmed samplesR Kannangai, S Ramalingam, K J Prakash, et al.
Theranostics|March 5, 2021
Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosisShuo Zhang, Zhen Chen, Puyu Shi, et al.
Pageof 51

Showing results (221-230 of 502) with videos related to

Sort By:
Pageof 51
Cancer Biology & Therapy|January 13, 2012
Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancerYikun Li, Songqing Fan, Junghui Koo, et al.
Cancer Biology & Therapy|July 9, 2011
Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagyCheng-Xiong Xu, Liqun Zhao, Ping Yue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guidelineNatasha B Leighl, Natasha Rekhtman, William A Biermann, et al.
Cancer|April 22, 2020
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16qBrian Pedro, Manali Rupji, Bhakti Dwivedi, et al.
The Oncologist|September 30, 2024
Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancerJaime Shaw, Xerxes Pundole, Akhila Balasubramanian, et al.
Journal of Health Care for the Poor and Underserved|August 18, 2025
A Report on Georgia Cancer Disparities and an Economic Evaluation of a Statewide Cancer Clinicians and Scholars' ProgramJon A Hoin, Kylie Brown, Joseph Lipscomb, et al.
Frontiers in Oncology|February 11, 2026
TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naïve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterationsThomas Newsom-Davis, Barbara Melosky, Rebecca S Heist, et al.
Clinical and Diagnostic Laboratory Immunology|November 4, 2000
Molecular confirmation of human immunodeficiency virus (HIV) type 2 in HIV-seropositive subjects in south IndiaR Kannangai, S Ramalingam, K J Prakash, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 22, 2001
A peptide enzyme linked immunosorbent assay (ELISA) for the detection of human immunodeficiency virus type-2 (HIV-2) antibodies: an evaluation on polymerase chain reaction (PCR) confirmed samplesR Kannangai, S Ramalingam, K J Prakash, et al.
Theranostics|March 5, 2021
Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosisShuo Zhang, Zhen Chen, Puyu Shi, et al.
Pageof 51